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Summary An oestrogen sensitive rat mammary tumour was grown in two groups of female and one group of
male hooded rats. The male group and one of the female groups were supplemented with oestrogen. The
tumours grew most rapidly in the female supplemented group. When the tumours reached 1.5 cm in diameter
they were harvested and the cell cycle distribution and number ofcells actively synthesising DNA (bromodeox-
yuridine (BrdU) labelling index) determined in each case. Chemical extracts were prepared from each tumour
and the concentration of phosphorus-containing metabolites determined using high resolution NMR spectro-
scopy. The concentration of phosphocholine was found to correlate strongly with the number of cells in
S-phase and the number of cells labelled with BrdU, whilst a highly significant negative correlation was
observed between these two parameters and glycerophosphocholine. The concentration of phos-
phoethanolamine did not correlate with either of these measures of proliferation rate. The concentration of
glycerophosphorylethanolamine showed a weak negative correlation with the number of cells in S-phase.
3'P NMR spectroscopy is a technique by which the pool sizes
of phosphorus-containing metabolites can be monitored in
intact tissue. The non-invasive nature of NMR spectroscopy
enables repeated determinations to be carried out on
the same tissue. Typical spectra from tumours contain
resonances from nucelotide triphosphate (NTP), inorganic
phosphorus (Pi) and an assortment of phosphodiesters and
phosphomonoesters (PMEs) including the phospholipid
metabolites phosphoethanolamine (PE) and phosphocholine
(PC).
PE and PC are substrates for the rate limiting step in the
synthetic pathways for phosphatidylcholine (Ptdcho) and
phosphatidylethanolamine (Ptdeth) respectively. They are
produced by the phosphorylation of choline and ethanol-
amine by their respective kinase (Vance & Choy, 1979; Tij-
burg et al., 1989). PE and PC can also be formed by the
action ofphospholipase C on Ptdeth and Ptdcho respectively.
Thus PE and PC are both anabolites and catabolites of their
respective phospholipids.
Therapy-induced changes in the growth rate of human
neuroblastoma (Maris et al., 1985) and breast carcinomata
(Sijens et al., 1988; Glaholm et al., 1989) have been shown to
be accompanied by changes in the PME content of the
tumours. The PME region of NMR spectra from both
neuroblastoma and breast tumours is composed primarily of
PC and PE (Maris et al., 1985; Smith et al., 1991a). In vitro
studies using cell culture lines have shown that the concentra-
tion of these two compounds in confluent populations of
tumour cells is much lower than in cells in the logarithmic
phase of growth (Daly et al., 1987; Warden & Friedkin,
1985). These results suggest an association between the con-
centration of PE and PC and tumour proliferation rate.
In the present study we have induced a rat mammary
tumour to grow at different rates by exploiting its sensitivity
to oestrogen. The concentration of PC, PE, glycerophos-
phocholine (GPC) and glycerophosphoryethanolamine (GPE)
were then determined in extracts from each tumour and
compared with proliferative data.
Experimental
Tumours
OESHR1 in an oestrogen-sensitive mammary tumour which
was originally induced in rats using oestrogen (Senior et al.,
1985). One mm3 pieces of an OESHR1 tumour were implant-
ed into the flanks of two groups of female hooded rats and
one group of male rats. The male group and one of the
female group (F + ) were supplemented with oestrogen. This
was achieved by implanting pellets consisting of a mixture of
estrone 15 mg/rat and cholesterol into the necks of the
animals. The third female group (F -) was left unsupple-
mented. When the tumours had grown to about 1.5 cm in
diameter they were harvested from each of the groups.
Harvesting of tumours
Bromodeoxyuridine (BrdU) was injected (100mg kg-', 8 mg
ml-' of saline) into the peritoneum of each animal. Four
hours later the animals were anaethetised using halothane
and the tumours exposed and freeze clamped using stainless
steel tongues pre-cooled in liquid nitrogen. After excision the
tumours were ground to a fine powder under liquid nitrogen.
Two hundred mg of the ground tissue were used to prepare
nuclei as described below. Metabolites were extracted from
the remaining powdered tissue.
Extraction ofmetabolites
Metabolites were extracted from tumour tissue using a
chloroform/methanol/tris buffer solvent system (Graham et
al., 1987). Briefly, after addition of 10 mmoles of EDTA
(0.4 M) per gram of tumour, the tissue was homogenised in
an ice-cold mixture of methanol and chloroform (2:1)
(3.75 ml g-' tissue) and the suspension left for 60 min at 4'C.
Chloroform (1.25 ml g-' tissue) was then added to the mix-
ture followed by 10 mM tris buffer (pH 7.0) (1.25 ml g-'
tissue). The mixture was then centrifuged at 1000g for
15 min at 4'C. The aqueous phase was removed and after
addition of 2.5 pLM of methylene diphosphonic acid (MDPA)
the pH was adjusted to 7.4.
NMR spectroscopy
The samples were examined on a Bruker Spectrospin NMR
spectrometer operating at 100 MHz (for 3Ip). All measure-
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ments were performed under proton-decoupled conditions in
a 10 mm probe. The decoupler was gated offbetween acquisi-
tions. The parameters used for each acquisition were: sweep
width 7937 Hz; acquisition time 0.5ms; repetition time 6 s
(We have previously shown that each of the metabolites are
fully relaxed after this time (Smith et al., 1991b)).
Peak assignments were verified in sample extracts by
repeating the NMR measurement of pH 7.4 and pH 6.6 with
the addition of commercially obtained metabolites.
Quantification was carried out by peak area estimation
using the spectrometer's integration facility.
Determination ofBrdU labelling index
Quantification of the percentage of cells labelled with BrdU
was carried out using the method of McNally and Wilson
(1990). This involves several steps and is described below.
Dissagregation oftumour tissue
A 200 mg sample of the freeze-clamped tumour tissue which
had been ground to a powder as described previously (har-
vesting of tumours) was added to 5 ml of phosphate buffered
saline (PBS) and the mixture centrifuged at 300g for 5 min.
The pellet was resuspended in 1 ml of PBS and then drawn
repeatedly into a 1 ml pipette tip. This was continued until
only connective tissue remained. The suspension was diluted
to 5 ml with PBS and then filtered through 35fLM nylon mesh
in a Swinnex holder. The suspended cells were then pelleted
by centrifugation at 300g for 5 min and resuspended in 1 ml
of PBS. Nine ml of cold ethanol was added to the cell
suspension whilst vortexing. The fixed cells were then stored
at 4°C for a minimum of 24 h.
Preparation ofnuclei
Fixed cells were pelleted by centrifugation at 300g for 10 min
and the pellet resuspended in 10 ml of pepsin solution
(0.4 mg ml-' in 0.1 M HCI). The suspension was then incu-
bated for 60 min at 37°C with intermittant shaking. After
filtration through 35piM nylon mesh, the nuclei were pelleted
by centrifugation at 500 g. They were then resuspended in
5 ml PBS and counted on a haemocytometer.
Labelling ofnuclei
Freshly prepared nuclei were pelleted by centrifugation at
500g for 5 min and then resuspended in 2M HCI at a cell
density of 1.5 x 106ml-'. The suspension was incubated at
room temperature for 30 min to denature the DNA after
which 5 ml of PBS was added and the nuclei centrifuged at
500g for 5 min. The nuclei were then washed in 10ml of
PBS and resuspended in 200yl of labelling solution (PBS
containing 0.5% Tween-20, 0.5% foetal calf serum). Ten yl
of rat anti-BrdU monoclonal antibody (supernatant, ICR2)
was added to the suspension and the mixture incubated in
darkness at room temperature. After 60 min the nuclei were
washed twice in 10 ml of PBS and then resuspended in 200 ILI
of labelling buffer. Ten ll of goat anti-rat IgG (whole
molecule) fluorescein conjugate (Sera Labs) was added and
the suspension was incubated for 60 min at room tempera-
ture to label BrdU-anti-BrdU complexes in the nuclei. The
suspension was then washed twice in 5 ml of PBS and the
nuclei resuspended in 3ml of PBS containing 10 sgml-'
propidium iodide (PI).
Flow cytometry
Flow cytometric measurements were made using an Ortho
Cytofluorograft 50H with a Lexel argon-ion laser producing
50 mW at 488 nm. Data were acquired and analysed on an
Ortho 2150 computer system. DNA content was measured as
red fluorescence (>630 nm) from PI. A display of the peak
vs the area of the signal of red fluorescence was used to gate
out debris and any clumped nuclei (Ormerod, 1990). After
further gating on a display of orthogonal vs forward light
scatter at 488 nm, the green (fluorescein, 520 nm) vs red
(DNA) fluorescence was recorded in a bivariate histogram
(cytogram). The phase of the cell cycle was determined from
the DNA content which was correlated with the green fluore-
scence from cells which were synthesising DNA at the time of
injection of BrdU. A separate histogram of DNA fluore-
scence was also recorded.
The percentage of tumour cells in each phase of the cell
cycle was estimated by using a computer program which
deconvolves a DNA histogram into GI, S and G2/M phases
(Ormerod et al., 1987). Regions were set on the histogram to
exclude the host cells from the analysis (see Figure 1). The
labelling index was expressed as the percentage of tumour
cells which had taken up BrdU and was estimated from the
cytogram of BrdU vs DNA fluorescence (see Figure 2). The
duration of S phase was measured from the movement of
BrdU-labelling cells through the cell cycle in the 4 h between
labelling with BrdU and removal of the tumour (Begg et al.,
1985).
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Figure 1 DNA histogram from a tumour grown in a female rat
supplemented with oestrogen a, a male rat supplemented with
oestrogen b, and an unsupplemented rat c (H = host cells; GI S
and G2 = cells in GI, S and G2 phases of cell cycle respectively;
X-axis = DNA content, Y-axis = number of cells).
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Table I BUdR labelling index, percentage oftumour cells in S-phase
and duration of S-phase ofeach tumour. Group means and standard
deviations for each parameter are included
Duration of Cells in
Group Tumour S-phase LI S-phase (%)
F+ 1 8.9 26 43.3
2 7.1 25.9 35.7
3 11.6 17.4 24.2
4 8.7 22.6 36.6
Mean± s.d. 9.1±1.9 23±4.0 35.0±7.9
M+ 1 7.1 14.4 25.2
2 6.9 9.4 21.9
3 7.1 11.1 20.1
4 7.2 10.4 22.1
Mean±s.d. 7.1±0.1 11.3±2.2 22.3±2.1
F- 1 7.7 8.7 19.9
2 7.4 16.7 26.5
3 8.7 14.6 26.3
4 4.6 16.2 20.6
Mean±s.d. 7.1±1.8 14.1±3.7 23.3±3.6
too
Figure 2 A contour plot of a cytogram of red (DNA) vs green
(BrdU) fluorescence recorded from a rat mammary tumour
implanted into a female. BrdU was injected 4 h before removal of
the tumour. The DNA content located the diploid host cells in
GI/GO of the cell cycle (H), the aneuploid tumour cells in GI/GO
(GI), S and G2M phases (G2). The cells which were actively
synthesising DNA at the time of injection of BrdU can be
identified by their green fluorescence. During the 4 h interval
before removal of the tumour, the cells originally in late S phase
had moved through G2, divided and were observed in GI (the
quadrant marked 'A'); cells from mid-S were observed in G2 and
those in early S in mid/late S phase (quadrant B). The percentage
of labelled cells (those in A plus B) gave the labelling index. The
length of S phase was calculated from the mean red fluorescence
of the labelled cells in S/G2 (quadrant B) which quantifies the
movement of cells through S phase (Begg et al., 1985).
Results
Tumour growth
Tumours grown in female rats supplemented with oestrogen
(F +) grew most rapidly reaching a diameter of 1.5 cm in 4
weeks. Those grown in supplemented male rats (M +) grew
at about half the rate of those in the female supplemented
group. Tumours grown in unsupplemented female rats (F -)
underwent an initial lag period ofseveral months, after which
their growth rate was comparable with the supplemented
groups.
Figure 1 shows an example of a DNA profile from a
tumour in each group. From this figure it can be seen that
tumour cells in OESHR1 are aneuploid. Host cells are pre-
sent in each tumour. Table I shows the percentage of tumour
cells labelled with BrdU (LI), the percentage of tumour cells
in S-phase and the duration of S-phase in each tumour.
Group mean values for each of these parameters are also
shown in Table I. There is no significant difference between
groups F + and F - (t = 1.53, ns) or groups M + and F -
(t = 0) in the mean duration of S-phase. There is a small
difference between groups F + and M + in the duration of
S-phase (t = 2.1, P<0.05). The mean LI for group F + is
about double that of group M + (t = 5.13, P (probability)
<0.005) parallelling the observed difference in growth rates
between the two groups. Although tumours in group F -
required 4 months to reach a diameter of 1.5 cm, the mean
LI and the mean number of cells in S-phase for this group is
comparable with tumours in group M + reflecting the more
rapid rate ofgrowth in the last few weeks prior to harvesting
of F -.
Phosphorus-containing metabolites in OESHRI
Figure 3 shows 31P NMR spectra from an extract of one of
the tumours from each of groups F +, M + and F -. The
i. -i
Figure 3 31P NMR spectra from a tumour grown in a unsupple-
mented rat a, a male rate supplemented with oestrogen b and a
female rat supplemented with oestrogen c.
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phosphomonester region of the tumour spectra were com-
posed primarily of PE with contributions from PC and
NMP. Glycerophosphorylcholine (GPC) and glycerophos-
phorylethanolamine (GPE) are present in each of the
tumours. The concentration of the former is comparable with
that of inorganic phosphorus (Pi) in some of the tumours.
The xNTP/ NDP region of the spectra includes resonances
from dinucleotides as well as nucleotides.
Group mean concentrations of PE, PC, NMP, GPC and
GPE are shown in Table II. The concentration of PC is
significantly higher in tumours from group F + than in those
from group M + (t= 3.71, P<0.005) or group F-
(t = 3.71, P<0.005). The concentration of PE is also higher
in group F + than group M + but this is onlyjust significant
(t= 1.96, P<0.05). The mean concentration of GPC in
group F + is lower than in group M + (t =2, P<0.05)).
Data from groups F +, M + and F - were pooled and
the concentration of PE, PC, GPC and GPE plotted against
LI and percentage of tumour cells in S-phase. PE did not
correlate with either of these parameters (Figure 4). The
concentration of PC was found to correlate strongly with
both LI (R = 0.70, P<0.01) and with the number of tumour
Table II Group mean concentrations ofphosphorus-containing com-
pounds in extracts from samples of rat mammary tumours
(Units: j.mol g'l tissue)
Treatment
Female Male Female
Metabolite + oestrogen + oestrogen unsupplemented
PE 0.8+0.19 0.58±0.12 0.67±0.24
PC 0.17±0.05 0.07±0.02 0.07±0.02
NMP 0.30±0.07 0.13±0.11 0.20±0.14
GPE 0.07±0.05 0.08±0.03 0.12±0.03
GPC 0.37±0.20 0.62±0.15 0.54±0.17
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cells in S-phase (R = 0.74, P<0.01). These plots are shown
in Figures 5a and b respectively. Figures 6a and b show plots
of GPC vs LI and percentage of tumour cells in S-phase. The
concentration of GPC shows a strong inverse correlation
with LI (R = 0.77, P<0.01) and number of cells in S-phase
(R = 0.80, P<0.01). GPE was found to correlate negatively
with the number of cells in S-phase (R = 0.67, P<0.05) but
not with LI (R = 0.46 ns). These are shown in Figure 7.
Discussion
Tumours grown in female rats supplemented with oestrogen
grew more rapidly than those in supplemented male rats.
This was reflected in the difference in the percentage of
tumour cells labelled with BrdU between the two tumour
groups. Shafie and Grantham (1981) have suggested that
prolactin may have an additive effect on the growth rate
induced by oestrogen on oestrogen-sensitive tumours. The
difference in growth rate between tumours grown in male and
female rats may therefore be a result ofgrowth modifications
by other compounds present in female rats.
The prominent metabolites observed in the PME and PDE
regions of 31P NMR spectra extracts from the OESHR1 rat
mammary tumour are the same as those found in human
breast carcinoma (Smith et al., 1991a). The principle compo-
nent of the PME region of spectra from the rat mammary
tumour is PE. The presence of high concentrations of this
compound has been observed in several different tumours
(Proietti et al., 1986; Corbett et al., 1987; Evanochko et al.,
1984). However, its presence in RIFI (Evanochko et al.,
1984) and Friend Leukaemic cells (Proietti et al., 1986) in
culture appears to be dependent on the presence of ethanol-
amine in the culture medium. In the absence of the latter
from the median PE was not detected in either cell line. PC
was also detected in the PME region of each tumour.
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Figure 4a Concentration of PE (umol g-' tissue) vs percentage
of tumour cells actively synthesising DNA (y = 0.5564
= 0.0079 x R = 0.25 ns). b, Concentration of PE (lsmol g-' tis-
sue) vs percentage of cells in S-phase (y = 0.4373 + 0.0092 x
R = 0.35 ns).
Figure 5a Concentration of PC (smol g-' tissue) vs percentage
of tumour cells actively synthesising DNA (y = - 0.0113 =
0.0069 x R = 0.70 P>0.01). b, Concentration of PC (pmol g'l
tissue) vs percentage of cells in S-phase (y = - 0.0571 + 0.0058 x
R=0.74 P>0.01).
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Figure 6a Concentration of GPC (tmol g-' tissue) vs percentage
of tumour cells actively synthesising DNA (y = 0.903 - 0.025 x
R = 0.77 P<0.01). b, Concentration of GPC (pmol g'l tissue) vs
percentage of cells in S-phase (y = 1.069 - 0.021 x R = 0.80
P<0.01).
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Figure 7a Concentration of GPE (umol g-' tissue) vs percentage
of tumour cells actively synthesising DNA (y
= 0.138 0.003 x
R = 0.46 ns). b, Concentration of GPE (umol g-' tissue) vs
percentage of cells in S-phase (y
= 0.186
- 0.004 x R = 0.67
P<0.05).
GPC and GPE are the major water soluble components of
the PDE region of the tumour. These two compounds are
degradative products of PtdCho and PtdEth respectively and
are produced by the action of phospholipase D on these two
phospholipids. The source of high concentrations of GPE
and GPC sometimes observed in tumours is controversial.
Evanochko et al. (1984) showed that with increasing size and
hence increasing necrotic content, the contribution of GPC
and GPE in RIF-l tumours increased. Based on this finding
they suggested that GPC and GPE are produced in areas of
necrosis as a consequence ofphospholipid degradation. How-
ever, two pieces of work have shown that treatment of
tumours with substances which induce necrosis, i.e. interferon
(Proietti et al., 1986) and tumour necrosis factors (Podo et
al., 1987), results in a decrease in the intra-tumour concentra-
tion of these two compounds. Further, in an earlier paper
(Smith et al., 1991b) we showed that some breast tumours
which histologically did not show necrosis contained appreci-
able concentrations of GPC and GPE.
The presence of PE and PC in the tumours may reflect
their role as phospholipid precursors. Several reports have
shown that increased PC levels in exponentially growing cells
when compared to confluent cells parallel increased activity
of choline kinase in these cells (Warden & Friedkin, 1985;
Paddon et al., 1982; Warden & Friedkin, 1984). The higher
concentration of this metabolite in the more rapidly prolifer-
ating tumours in the study may be consequence of upregula-
tion of choline kinase in response to demands from the cell
for increased phospholipid synthesis.
The phospholipid composition of cell membranes is main-
tained by a balance between their synthesis and degradation
(Dawson, 1973). In the present work we have shown that in
addition to an increase in PC there is a decrease in the GPC
content of tumours with increasing numbers of cells under-
going active DNA synthesis. The synthesis of Ptdcho is most
rapid in cells during S-phase (Bergeron et al., 1970). Thus the
findings of the present work may represent a shift to the
synthetic part of the synthesis/degradation cycle in the more
rapidly proliferating tumours.
The concentration of PE was shown not to be associated
with growth rate in this tumour. Even in the slowest growing
tumours the concentration of this compound is very high. It
is therefore probable that the level of PE is sufficient for
sustained phosphatidylethanolamine synthesis. Further as
discussed above the presence of this compound in cells
appears to be highly dependent on the availability ofethanol-
amine in the immediate environment and so its concentration
may be less diposed than PC to cellular control.
PE and PC may also be present in tumours as a conse-
quence of the hydrolysis of PtdEth and PtdCho respectively
by phospholipase C. These pathways are analogous to the
phospholipase C mediated hydrolysis of phosphatidylinosi-
tides (Ptdln). In each case diacylgylcerol (DAG) is produced
which can activate protein kinase C and initiate a cascade of
events resulting in cell proliferation. It is well established that
the agonist-induced cleavage of PtdIn is an important path-
way in the intracellular transduction of a growth stimulus
(Berridge, 1987). Evidence suggests that the hydrolysis of
PtdCho and in some cases PtdEth may also be involved in
initiating and sustained a growth signal (Billah & Anthes,
1990). The exposure of several cell types to tumour pro-
moters results in the hydrolysis of PtdCho (Guy & Murray,
1982; Besterman et al., 1986). Thus, Guy and Murray (1982)
showed that phorbol diesters cause stimulation of PtdCho
turnover in HeLa cells with a consequent rise in the concentra-
tion of PC. Besterman et al. (1986) showed that in addition to
phorbol diesters, serum and platelet derived growth factor
(PDGF) stimulate the hydrolysis of PthCho produced DAG
and PC in preadipocytic cells (3T3-L1) within minutes of cell
exposure. More recently, Martinson et al. (1989) have shown
that the increase in DAG concentration resulting from stimu-
lation of astrocytoma cells with phorbol diesters and car-
bochol is derived exclusively from PtdCho. Although the
hydrolysis of PtdEth in response to growth stimulus is con-
sidered to be less important than that of PtdCho (Billah &
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Anthes 1990; Kiss & Anderson, 1989) in some cells e.g.
cultured rat mesangial cells, interleukin-1 generates trans-
membrane signals by the hydrolysis of PtdEth (Kester et al.,
1989). Thus the choice of substrate for phospholipase C may
be dependent on the cell type. One study has shown that
oestrogen stimulates the phospholipase C hydrolysis of phos-
pholipids in MCF 7 breast tumour cells (Freter et al., 1986).
In the present study the concentration of PC showed a highly
significant correlation with the percentage of tumour cells
undergoing DNA synthesis. This may be a consequence of
enhanced phospholipase C induced hydrolysis of PtdCho
occurring in the more rapidly growing tumours when com-
pared with the less prolific tumours.
In summary, we have shown a strong association between
the proliferation rate of a rat mammary tumour and the PC
and GPC content ofthe tumour. The higher concentration of
PC in the more rapidly proliferating tumours when compared
with the slower growing ones may be a consequence of its
more rapid synthesis via choline kinase activity or/and a
more rapid rate of degradation of PtdCho by phospholipase
C as part of an intracellular signalling scheme. We are cur-
rently investigating these two possibilities.
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